title: The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers.
abstract: Ulcerative colitis is characterised by impairment of the epithelial barrier and tight junction alterations resulting in increased intestinal permeability. UC is less common in smokers with smoking reported to decrease paracellular permeability. The aim of this study was thus to determine the effect of nicotine, the major constituent in cigarettes and its metabolites on the integrity of tight junctions in Caco-2 cell monolayers. The integrity of Caco-2 tight junctions was analysed by measuring the transepithelial electrical resistance (TER) and by tracing the flux of the fluorescent marker fluorescein, after treatment with various concentrations of nicotine or nicotine metabolites over 48 h. TER was significantly higher compared to the control for all concentrations of nicotine 0.01-10 microM at 48 h (p<0.001), and for 0.01 microM (p<0.001) and 0.1 microM and 10 microM nicotine (p < 0.01) at 12 and 24 h. The fluorescein flux results supported those of the TER assay. TER readings for all nicotine metabolites tested were also higher at 24 and 48 h only (p < or = 0.01). Western blot analysis demonstrated that nicotine up-regulated the expression of the tight junction proteins occludin and claudin-1 (p < or = 0.01). Overall, it appears that nicotine and its metabolites, at concentrations corresponding to those reported in the blood of smokers, can significantly improve tight junction integrity, and thus, decrease epithelial gut permeability. We have shown that in vitro, nicotine appears more potent than its metabolites in decreasing epithelial gut permeability. We speculate that this enhanced gut barrier may be the result of increased expression of claudin-1 and occludin proteins, which are associated with the formation of tight junctions. These findings may help explain the mechanism of action of nicotine treatment and indeed smoking in reducing epithelial gut permeability.
authors.affiliation: Northern Ireland Centre for Food and Health (NICHE), Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, Northern Ireland, UK.
authors.forename: V E
authors.initials: VE
authors.lastname: McGilligan
authors.forename: J M W
authors.initials: JM
authors.lastname: Wallace
authors.forename: P M
authors.initials: PM
authors.lastname: Heavey
authors.forename: D L
authors.initials: DL
authors.lastname: Ridley
authors.forename: I R
authors.initials: IR
authors.lastname: Rowland
mesh_terms: D015153:Blotting, Western; D018938:Caco-2 Cells; D002851:Chromatography, High Pressure Liquid; D062445:Claudin-1; D003093:Colitis, Ulcerative / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D017097:Electric Impedance; D019793:Fluorescein / Q000378:metabolism; D005456:Fluorescent Dyes / Q000378:metabolism; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000166:cytology / Q000503:physiopathology; D008565:Membrane Proteins / Q000378:metabolism*; D009538:Nicotine / Q000494:pharmacology*; D062793:Occludin; D010539:Permeability / Q000187:drug effects; D012907:Smoking; D019108:Tight Junctions / Q000187:drug effects* / Q000378:metabolism
chemical_list: C568108:CLDN1 protein, human; D062445:Claudin-1; D005456:Fluorescent Dyes; D005731:Ganglionic Stimulants; D008565:Membrane Proteins; C568985:OCLN protein, human; D062793:Occludin; D009538:Nicotine; D019793:Fluorescein